# Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation

> **NCT00970489** · PHASE3 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 1516 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Omega -3 fatty acids
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00970489
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 1516 (ACTUAL)
- **Last updated:** 2017-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00970489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00970489, "Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00970489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*